5%+ stake
5.1%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Loading…
Traded Oct 30, 2025 · Filed Oct 31, 2025
Trane Technologies's VP & Chief Accounting Officer sold $264K of Trane Technologies shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$264,000
Shares × reported transaction price
on the day of results (Oct 30, 2025), 91 days before results of Jan 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $446.37 on Oct 30, 2025, 42% above its 52-week low and 6% below its high, after an 11% rise over the previous 30 trading days
52-week range $315.21 (Apr 8, 2025) to $472.54 (Jul 28, 2025), 83% of the way up, from 250 adjusted closes. 30 trading days earlier: $402.49 on Sep 18, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -2.9% | -0.3% | -2.6% |
| 30 days | -8.3% | +0.1% | -8.4% |
| 90 days | -4.8% | +1.8% | -6.5% |
| 180 days | +9.0% | +5.1% | +3.9% |
Past results only. Not a forecast.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
